C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
08/2011
08/17/2011	CN102153560A Rectification method of allopurinol
08/17/2011	CN102153559A Novel method for synthesizing sitagliptin phosphate and derivative thereof
08/17/2011	CN102153558A Derivative of multi-target antitumor inhibitor 2-aminopyrrole-triazine and synthesis method thereof
08/17/2011	CN102153557A Chiral center nitrogen heterocyclic carbine precursor salt with quadrol skeleton, synthetic method and application
08/17/2011	CN102153556A Triazolopyrimidine compound and preparation method thereof
08/17/2011	CN101307052B Method for preparing pyrrole-N-heterocyclic ring derivates and medical application thereof
08/17/2011	CN101035789B (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane
08/16/2011	US7999106 Processes for the preparation of clopidogrel hydrogen sulfate polymorphic form I
08/16/2011	US7998966 Axl kinase inhibitors
08/16/2011	US7998963 Arylpiperazine derivatives and uses thereof
08/16/2011	US7998954 Pyrimidodiazepinone derivative
08/16/2011	US7998952 Thiolactams and uses thereof
08/16/2011	US7998951 treating hepatitis C infection; 6-cyclohexyl-2,3-dihydro-5-phenyl-1,4-oxazino[2,3,4-hi]indole-9-carboxylic acid
08/16/2011	CA2629777C Spirocyclic compounds as hdac inhibitors
08/16/2011	CA2614603C Azolo triazines and pyrimidines
08/11/2011	WO2011097553A1 Pyridazine derivatives useful as cannabinoid - 2 agonists
08/11/2011	WO2011097331A1 Crystalline forms of (s)-1-(4-(5-cyclopropyl-1h-pyrazol-3- ylamino)pyrrolo [1,2-f] [1,2,4] triazin-2-yl)-n-(6-fluoropyridin- 3-yl)-2-methylpyrrolidine-2-carboxamide
08/11/2011	WO2011097087A1 Pyrrolo [ 2, 3 - d] pyrimidine urea compounds as jak inhibitors
08/11/2011	WO2011095625A1 1,2,4-triazine-4-amine derivatives
08/11/2011	WO2011095556A1 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds
08/11/2011	WO2011095068A1 Pharmaceutically acceptable salts of pyrrolo-nitrogenous heterocyclic derivatives, preparation method and medical use thereof
08/11/2011	WO2011095057A1 Benzimidazole derivatives and pharmaceutical compositions and uses thereof
08/11/2011	WO2011094823A1 Compounds for treating respiratory syncytial virus infections
08/11/2011	US20110196155 Crystalline forms of pemetrexed diacid and processes for the preparation thereof
08/11/2011	US20110196154 Amorphous pemetrexed disodium
08/11/2011	US20110196149 Fluoridation method
08/11/2011	US20110196148 Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases
08/11/2011	US20110196012 Deuterated macrocyclic inhibitors of viral ns3 protease
08/11/2011	US20110195958 Activators of human pyruvate kinase
08/11/2011	US20110195957 Substituted diazepan orexin receptor antagonists
08/11/2011	US20110195951 Diazaindole derivatives and their use in the inhibition of c-jun n-terminal kinase
08/11/2011	US20110195950 Organic Compounds
08/11/2011	US20110195948 Substituted Pyrazolo[1,5-a]Pyrimidine Compounds as TRK Kinase Inhibitors
08/11/2011	US20110195934 Azolopyrrolone melanin concentrating hormone receptor-1 antagonists
08/11/2011	US20110195929 Compounds for the treatment of flaviviral infections
08/11/2011	CA2789279A1 1,2,4-triazine-4-amine derivatives
08/11/2011	CA2789151A1 Pyridazine derivatives useful as cannabinoid-2 agonists
08/11/2011	CA2789093A1 Compounds for treating respiratory syncytial virus infections
08/11/2011	CA2788071A1 Pyrrolo [ 2, 3 - d] pyrimidine urea compounds as jak inhibitors
08/11/2011	CA2787291A1 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds
08/11/2011	CA2786927A1 Pharmaceutically acceptable salts of pyrrolo-nitrogenous heterocyclic derivatives, preparation method and medical use thereof
08/10/2011	EP2354140A1 Pyrrolopyridines useful as inhibitors of protein kinase
08/10/2011	EP2354139A1 Pyrrolopyridines useful as inhibitors of protein kinase
08/10/2011	EP2354124A2 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
08/10/2011	EP2352731A1 Gamma secretase modulators
08/10/2011	EP2247593B1 Pyrrolopyrazine kinase inhibitors
08/10/2011	EP2229396B1 Spiroindolinone derivatives
08/10/2011	EP2190815B1 Pyrrolidine aryl-ether as nk3 receptor antagonists
08/10/2011	EP1751163B1 Benzazepine compounds having affinity for dopamine d3 receptor and uses thereof
08/10/2011	EP1626971B1 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines
08/10/2011	EP1609781B1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine
08/10/2011	EP1296986B1 5-aminoalkyl-pyrazolo[ 4,3-d]pyrimidines with a phosphodiesterase v-inhibiting effect
08/10/2011	CN1980600B Synthesis of porphyrins designed for attachment to electroactive surfaces via one or more carbon tethers
08/10/2011	CN1972940B Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists
08/10/2011	CN1882591B 5,7-diaminopyrazolo '4,3-d!pyrimidines with pde-5 inhibiting activity
08/10/2011	CN1129942B Aza spiro-compounds acting on the cholinergic system with muscarinic agonist activity
08/10/2011	CN102149716A A process for preparing [1S- [1-Alpha, 2-Alpha, 3-Beta (1S, 2R) 5-Beta] ]-3- [7- [2- (3, 4-difluorophenyl) -cyclopropylamino]- 5- (propylthio) -3H-1, 2, 3-triazolo [4, 5-d]pyrimidin-3-yl]-5- (2- hydroxyethoxy) cyclopentane-1, 2-diol and to its intermediates
08/10/2011	CN102149714A Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same
08/10/2011	CN102146217A Pigment particle dispersion, light-cured composition and novel compound used in the dispersion
08/10/2011	CN102146084A 3-cyan-6-aminoquinoline derivatives, preparation method thereof and application thereof in medicines
08/10/2011	CN102146082A Medicinal salts of pyrrolo-nitrogenous heterocyclic derivatives, and preparation method and application thereof to medicines
08/10/2011	CN102146081A Indoleacetic acid derivatives and preparation method and application thereof
08/10/2011	CN102146065A Method for preparing high-purity diketopiperazine cyclopeptide
08/10/2011	CN102146053A 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of inflammatory or immunological disorders
08/10/2011	CN101671337B Citric acid aildenafil crystal form A and preparation method and usage thereof
08/10/2011	CN101607961B Eszopiclone crystal and composition thereof
08/10/2011	CN101333173B N-[4-(butanal-4-group)-benzoyl]-L-glutamic acid dimethyl ester compound and method for preparing pemetrexed by using the compounds
08/10/2011	CN101323617B 2,3,4,7-polysubstituted naphthyridine [4,3-d] pyrimidine derivates with sterilization activity and preparation thereof
08/10/2011	CN101287738B Imidazo benzodiazepine derivatives
08/10/2011	CN101242832B Fused pyrazole as p38 MAP kinase inhibitors
08/09/2011	US7994423 Charge-transport materials, methods of fabrication thereof, and methods of use thereof
08/09/2011	US7994312 Synthetic route to ABCD-porphyrins
08/09/2011	US7994199 Heterocyclic compounds, methods for the preparation thereof, and uses thereof
08/09/2011	US7994180 Processes for preparing intermediates of pemetrexed
08/09/2011	US7994172 [1H-pyrazolo[3, 4-D]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (P70s6k, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases
08/09/2011	US7994168 Hexahydro-pyrazino[1,2-A]pyrimidine-4,7-dione derivatives substituted with amino acids
08/09/2011	US7994167 Pentafluorosulphanyl-substituted compound and its use for producing medicaments
08/09/2011	US7994162 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same
08/09/2011	US7994160 Pyridazine compounds as glycogen synthase kinase 3 inhibitors
08/09/2011	US7994156 Carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
08/09/2011	US7994142 Agents containing folic acid, vitamin B6 and vitamin B12, and the use thereof
08/09/2011	US7994093 Heterocyclocarboxamide derivatives
08/09/2011	US7993760 Compound for use in organic electroluminescent device and organic electroluminescent device
08/09/2011	CA2540768C Pyrazolo and imidazo-pyrimidine derivatives
08/09/2011	CA2441146C Fluorescent cobalamins and uses thereof
08/04/2011	WO2011094628A1 Compositions and methods for treating toxoplasmosis. cryptosporidiosis and other apicomplexan protozoan related diseases
08/04/2011	WO2011094434A2 7-azoniabicyclo [2.2.1] heptane derivatives, methods of production, and pharmaceutical uses thereof
08/04/2011	WO2011094290A1 Pyrazolopyrimidine kinase inhibitors
08/04/2011	WO2011094288A1 Pyrazolopyrazine kinase inhibitors
08/04/2011	WO2011093672A2 Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase
08/04/2011	WO2011093609A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
08/04/2011	WO2011093365A1 Nitrogenated heterocyclic compound
08/04/2011	WO2011093352A1 Thiazole derivative
08/04/2011	WO2011092272A1 Gamma secretase modulaters
08/04/2011	WO2011092198A1 5-alkynyl-pyrimidines
08/04/2011	WO2011092197A1 5-alkynyl pyrimidines and their use as kinase inhibitors
08/04/2011	WO2011092120A1 6,7- dihydroimidazo [1,5-a] pyrazin-8 (5h) - one derivatives as protein kinase modulators
08/04/2011	WO2011091614A1 7-(2-substituted-3-amino-1-tetrahydropyrrolo[3,4-c]pyrazolyl)quinoline carboxylic acid derivatives, their preparation methods and uses against bacterium and tuberculosis
08/04/2011	WO2011091607A1 Copolymer containing fluorenylporphyrin-anthracene, preparation method and use thereof
08/04/2011	WO2011041747A3 Neutral mixed ligand transition metal complexes as active materials in solid-state organic photovoltaic devices

1 ... 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 ... 573